CALGB 80403/E1206: Randomized Phase II Study of ECF-C, IC-C, or Folfox-C in Metastatic Esophageal and GE Junction Cancer.
Phase of Trial: Phase II
Latest Information Update: 17 Mar 2017
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Epirubicin; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 05 Jul 2016 Results published in the Journal of Clinical Oncology
- 06 Jun 2016 Status changed from active, no longer recruiting to completed.
- 15 Oct 2014 Status changed from recruiting to active, no longer recruiting, as per ClinicalTrials.gov record.